Clinical Trials Browser

Phase 2 × pasireotide × 1 year × Clear all

NCT06295952 2026-03-04

A Study of Pasireotide in People With Prolactinoma

Phase 2 Recruiting

Prolactin-Producing Pituitary Tumor

NCT01313559 2025-04-30

Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer

Phase 2 Terminated

6 enrolled 10 charts

Prostatic Neoplasms